Clinical Trials List
2013-08-01 - 2015-05-31
Others
Terminated5
ICD-10H35.051
Retinal neovascularization, unspecified, right eye
ICD-10H35.052
Retinal neovascularization, unspecified, left eye
ICD-10H35.053
Retinal neovascularization, unspecified, bilateral
ICD-10H35.059
Retinal neovascularization, unspecified, unspecified eye
ICD-9362.16
Retinal neovascularization NOS
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHANG-HAO YANG Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 莊智鈞 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 莊秋同 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
50 participants
